These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6737503)

  • 1. Incidence of lymph node involvement in localized carcinoma of the prostate.
    Reddy EK; Mebust WK; Weigel JW; Giri S; Mansfield CM
    J Natl Med Assoc; 1984 May; 76(5):463-6. PubMed ID: 6737503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer.
    Fowler JE; Whitmore WF
    Cancer; 1981 Jun; 47(12):2941-5. PubMed ID: 7260881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic lymphadenectomy for stage B1 adenocarcinoma or the prostate: justified or not?
    Nicholson TC; Richie JP
    J Urol; 1977 Feb; 117(2):199-201. PubMed ID: 833968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases.
    Zincke H; Farrow GM; Myers RP; Benson RC; Furlow WL; Utz DC
    J Urol; 1982 Sep; 128(3):498-501. PubMed ID: 7120555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinoma. Influence of tumor grade on results of pelvic lymphadenectomy.
    Donohue RE; Fauver HE; Whitesel JA; Augspurger RR; Pfister RR
    Urology; 1981 May; 17(5):435-40. PubMed ID: 7233656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases.
    McDowell GC; Johnson JW; Tenney DM; Johnson DE
    Urology; 1990 Jun; 35(6):476-82. PubMed ID: 2353374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer.
    Arai Y; Yoshiki T; Yamabe H; Yoshida O
    Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
    Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
    Saltzstein SL; McLaughlin AP
    Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer.
    Petros JA; Catalona WJ
    J Urol; 1992 Jun; 147(6):1574-5. PubMed ID: 1593688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraprostatic tumor location and pelvic lymph node metastatic pattern in early prostate cancer.
    Nseyo UO; Pontes JE
    Urology; 1989 Mar; 33(3):171-4. PubMed ID: 2919475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients.
    Smith JA; Seaman JP; Gleidman JB; Middleton RG
    J Urol; 1983 Aug; 130(2):290-2. PubMed ID: 6876275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
    Middleton RG
    NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
    Elfving P; Lundgren R
    Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.